Trials / Unknown
UnknownNCT04094467
Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection
CLASSICAL ANTAGONIST PROTOCOL IN COMPARISON WITH AGONIST STOP PROTOCOL IN Polycystic Ovary Symdrome WOMEN UNDERGOING Intra-cytoplasmic Injection TRIAL: a Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
Stein and Leventhal were the first to recognize an association between the presence of polycystic ovaries and signs of hirsutism and amenorrhea (eg,oligomenorrhea, obesity), After women diagnosed with Stein-Leventhal syndrome underwent successful wedge resection of the ovaries, their menstrual cycles became regular, and they were able to conceive. As a consequence, a primary ovarian defect was thought to be the main culprit, and the disorder came to be known as polycystic ovarian disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cetrorelix | 0.25 mg subcutaneous injection daily for 6 days |
| DRUG | Leuprolide Acetate | 0.1 mg subcutaneous injection daily for 12 days |
Timeline
- Start date
- 2019-12-07
- Primary completion
- 2020-10-01
- Completion
- 2021-01-01
- First posted
- 2019-09-19
- Last updated
- 2020-03-25
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04094467. Inclusion in this directory is not an endorsement.